KRAS and inflammatory bowel disease: Genetic alteration due to inflammation or mutations in TP53 (Tumor Protein 53) and KRAS (Kirsten rat sarcoma viral oncogene homolog) genes and gut dysbiosis is thought to be the cause of IBD-associated CRC development [13].